Friday December 15th 2017

A Phase I/II Study of Pixantrone in Patients with an Agressive Relapsing-Remitting or SecondaryProgressive Multiple Sclerosis (PIXAMS) (P3.170)

CONCLUSIONS: PIX is as effective as MX but less cardiotoxic and could be an alternative in aggressive MSStudy Supported by: Fondation Charcot StichtingDisclosure: Dr. Gonsette has nothing to disclose. Dr. Edan has received personal compensation for activities with Bayer Pharmaceuticals Corp., Biogen Idec, Teva Neuroscience, Novartis, and LFB. Dr. Debouverie has received personal compensation for activities with Biogen Idec, Bayer Schering, Merck Serono, Novartis, Sanofi-Aventis Pharmaceuticals Inc., and Teva Neuroscience. Dr. Sindic has received personal compensation for activities with Biogen Idec, Novartis, Sanofi-Genzyme, Teva Neuroscience, Bayer Schering and Merck Serono. Dr. Sindic has received research support from Bayer Schering. Dr. Ferre has nothing to disclose. (Source: Neurology…

Jump to original – 

A Phase I/II Study of Pixantrone in Patients with an Agressive Relapsing-Remitting or SecondaryProgressive Multiple Sclerosis (PIXAMS) (P3.170)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]